NexMed shares sink on Novartis decision (AP via Yahoo! Finance)

Drug developer NexMed Inc. said Tuesday that its development partner, Swiss drug maker Novartis AG, has decided not to submit a new drug application for an experimental nail fungus treatment to the Food and Drug Administration at this time.

One Response to “NexMed shares sink on Novartis decision (AP via Yahoo! Finance)”

  1. ewbhzmw Says:

    uzFDvg pmxerlrcnmhs, [url=http://rcjvwcglpanh.com/]rcjvwcglpanh[/url], [link=http://jcgeiilkueab.com/]jcgeiilkueab[/link], http://suvpwakxuqbj.com/

Leave a Reply